1. Home
  2. SXT vs DYN Comparison

SXT vs DYN Comparison

Compare SXT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXT
  • DYN
  • Stock Information
  • Founded
  • SXT 1882
  • DYN 1984
  • Country
  • SXT United States
  • DYN United States
  • Employees
  • SXT N/A
  • DYN N/A
  • Industry
  • SXT Major Chemicals
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • SXT Industrials
  • DYN Health Care
  • Exchange
  • SXT Nasdaq
  • DYN Nasdaq
  • Market Cap
  • SXT 3.4B
  • DYN 3.4B
  • IPO Year
  • SXT N/A
  • DYN 2020
  • Fundamental
  • Price
  • SXT $76.96
  • DYN $28.39
  • Analyst Decision
  • SXT Buy
  • DYN Strong Buy
  • Analyst Count
  • SXT 1
  • DYN 9
  • Target Price
  • SXT $85.00
  • DYN $52.44
  • AVG Volume (30 Days)
  • SXT 151.7K
  • DYN 1.0M
  • Earning Date
  • SXT 10-25-2024
  • DYN 11-12-2024
  • Dividend Yield
  • SXT 2.13%
  • DYN N/A
  • EPS Growth
  • SXT N/A
  • DYN N/A
  • EPS
  • SXT 2.09
  • DYN N/A
  • Revenue
  • SXT $1,530,110,000.00
  • DYN N/A
  • Revenue This Year
  • SXT $8.14
  • DYN N/A
  • Revenue Next Year
  • SXT $4.13
  • DYN N/A
  • P/E Ratio
  • SXT $36.80
  • DYN N/A
  • Revenue Growth
  • SXT 5.10
  • DYN N/A
  • 52 Week Low
  • SXT $55.02
  • DYN $9.82
  • 52 Week High
  • SXT $82.99
  • DYN $47.45
  • Technical
  • Relative Strength Index (RSI)
  • SXT 46.18
  • DYN 42.04
  • Support Level
  • SXT $77.55
  • DYN $27.99
  • Resistance Level
  • SXT $80.74
  • DYN $35.68
  • Average True Range (ATR)
  • SXT 1.74
  • DYN 2.09
  • MACD
  • SXT -0.07
  • DYN 0.23
  • Stochastic Oscillator
  • SXT 33.94
  • DYN 9.12

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

Share on Social Networks: